Larry Kaiser, M.D.
President

Susan Coulter, J.D.
Vice President, Office
of Institutional Advancement

Wendy K. Mohon
Editor

Michelle Rexroat
Web Developer I

March, 2005
Table of Contents

Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

 

New

H. Vernon Anderson, Medical School (MS), Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes (Merlin-TIMI 36), Brigham and Women's Hospital, $100,000.

Rowen J. Chang, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), Research Service Agreement-Industria Farmaceutica Serono, S.P.A., Industria Farmaceutica Serono S.P.A., $65,000.

Susan M. Cooley, MS, Reach Out and Read Texas, Reach Out and Read National Center, $30,000.

Kenichi Fujise, IMM, MS, Graduate School of Biomedical Sciences (GSBS), Molecular Prevention of Restenosis, American Heart Association, National, $500,000; and Characterization of Pariss, Eisai Co. Ltd., $117,000.

Jaime Gateno, Dental Branch, Computer Surgical Simulation for Craniofacial Surgery, Medical Modeling, LLC, $52,015.

Ralf Gebhard, MS, A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In- House Blinding Conditions, To Examine the Safety, Tolerability, and Efficacy of Two Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting, Merck & Co. Inc., $74,868.

Adelaide A. Hebert, MS, A Phase 3, Multicenter, Randomized, Double Blind, Vehicle Controlled Study of the SAF, Connetics Corporation, $129,610.

Chinnaswamy Jagannath, MS and GSBS, Baylor Center for AIDS Research, Baylor College of Medicine, $25,000.

Barry D. Kahan, MS and GSBS, Conversion from Mycopenolate Mofetil To Sodium Mycophenolic Acid, Novartis Pharmaceuticals Corp., $301,332.

Samia N. Khalil, MS, A Multicenter, Randomized, PONV in Female Subjects with Known Risk FacTors for PONV, Glaxo Smith Kline, $94,250.

Susan Landry, MS, Preschool Curriculum Evaluation Research Grant Program, Mathmatica Policy and Research, $8,684; and Baby/Child Library, Georgetown University, $10,000.

Dianna M. Milewicz, MS and GSBS, Identification of Biomarkers for Aneurysms and Dissections, Ted Nash Long Life, $200,000.

F. Gerard Moeller, MS and GSBS, A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study To Assess the Safety and Efficacy of Topiramate in the Treatment of Alcohol Dependence, Ortho McNeil Pharmaceutical Inc., $222,352.

Fernando R. Moya, A Phase III, Randomized, Double-Blind, Multi- Center Clinical Trial Comparing the Safety and Efficacy of Veronate® Versus Placebo for the Prevention of Nosocomial Staphylococcal Sepsis in Premature Infants (Birth Weight 500 - 1250 G), Inhibitex Inc., $103,500.

Luis Ostrosky-Zeichner, MS, Activity of Caspofungin for Treatment of Murine Fusariosis Using Taqman QPCR, Merck & Co. Inc., $89,178.

Evan G. Pivalizza, MS, A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of 2 Mg/Kg Bolus Plus 24-Hour 0.05 Mg/Kg/Hr Infusion of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass (Primo-CABG II), ProcTor & Gamble Pharmaceuticals Inc., $152,329.

Ronald Portman, MS, A Randomized, Double-Blind, Placebo Withdrawal, Parallel Group, Dose-Response Study To Evaluate the Efficacy and Safety of Eplernone in the Treatment of Hypertension in Children, Icon Clinical Research Inc., $198,120; and An Open- Label, Long-Term Study To Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children, Icon Clinical Research Inc., $197,370.

John A. Putkey, MS and GSBS, The Molecular Determinants of EC Coupling, Baylor College of Medicine, $27,618.

Renae R. Schumann, School of Nursing,Workforce Increases in Nurses and Nursing Faculty: Excellence in Resource Collaboration (WINNER), Texas Higher Education Coordinating Board, $1,529,244.

Renewal

Pawel A. Penczek, MS and GSBS, High Resolution in Single Particle Reconstruction, National Institutes of Health (NIH), $1,033,458.

Michael W. Ross, School of Public Health, Formative Research to Develop Behavioral Surveillance for STD Transmission Among High-Risk Heterosexual Populations, Texas Department of Health, $245,900.

Ah-Lim Tsai, MS and GSBS, Structure-Function and Reaction Mechanism of PGHS and ENOS, NIH, $1,411,777.